Evaluation of the efficacy of aprepitant on the prevention of chemotherapy-induced nausea and vomiting and quality of life with functional living index emesis.

Aksu G., Dolasik I., Ensaroglu F., Sener S. Y., Aydin F. H., Temiz S., ...More

Balkan medical journal, vol.30, no.1, pp.64-7, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 30 Issue: 1
  • Publication Date: 2013
  • Doi Number: 10.5152/balkanmedj.2012.087
  • Journal Name: Balkan medical journal
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.64-7
  • Keywords: Aprepitant, emezis, quality-of life, FLIE, chemotherapy, ANTAGONIST APREPITANT, CISPLATIN
  • Kocaeli University Affiliated: Yes

Abstract

Objective: Functional Living Index Emesis (FLIE) is developed to evaluate the relationship between emesis and it's effects on patient's daily life and is far more relevant to detect the effectiveness of antiemetic treatment compared with self-diary reports. In this study, the efficacy of oral neurokinin-1 antagonist aprepitant on the prevention of chemotherapy-induced nausea and vomiting and quality of life is evaluated with FLIE.